Natpara Updates
These are the updates about Natpara going back to September 2019.
June 2021
April 2021
April 2021 Call with HypoPara community summary
Takeda update letter to hypoparathyroidism community regarding recall status change
Supply of 100-mcg Natpara Interrupted for About 1 Year, Takeda Says
Takeda’s rare disease med Natpara faces long road back to market as manufacturing issues multiply
UPDATED: 2,400 people remain without rare disease drug as Takeda manufacturing woes continue
Feb - March 2021
Dec 2020
November 2020
October 2020
Jan 2020
Sept - Dec 2019
Natpar(a): A Case in Point for Rare Disease Drugs?
Drug Recall in US Causes Hypoparathyroid Patients Extreme Hardship
Recall of orphan drug leave patients in a lurch
Leahy Sanders Welch urges FDA swiftly to resolve critical drug recall
Patients left in limbo after medical recall
Takeda’s Natpara leaves patients health in limbo
Patients fear after parathyroid Natpara recall
Takeda November 2019 Proposals submitted to FDA
Takeda Recall Update October 2019
Takeda Class I Recall announcement
Takeda Special Use Program Letter
Takeda message about recall Sept